These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38111886)
21. Cardioprotection of Repeated Remote Ischemic Conditioning in Patients With ST-Segment Elevation Myocardial Infarction. Chen S; Li S; Feng X; Wang G Front Cardiovasc Med; 2022; 9():899302. PubMed ID: 35722122 [TBL] [Abstract][Full Text] [Related]
22. Assessment of global longitudinal strain and plasma natriuretic peptide in patients with asymptomatic left ventricular dysfunction. Ulziisaikhan G; Khurelbaatar MU; Khorloo C; Sodovsuren N; Khasag A; Unurjargal T Kardiologiia; 2021 Oct; 61(10):53-60. PubMed ID: 34763639 [TBL] [Abstract][Full Text] [Related]
23. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Howden EJ; Bigaran A; Beaudry R; Fraser S; Selig S; Foulkes S; Antill Y; Nightingale S; Loi S; Haykowsky MJ; La Gerche A Eur J Prev Cardiol; 2019 Feb; 26(3):305-315. PubMed ID: 30376366 [TBL] [Abstract][Full Text] [Related]
24. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction. Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial. Boekhout AH; Gietema JA; Milojkovic Kerklaan B; van Werkhoven ED; Altena R; Honkoop A; Los M; Smit WM; Nieboer P; Smorenburg CH; Mandigers CM; van der Wouw AJ; Kessels L; van der Velden AW; Ottevanger PB; Smilde T; de Boer J; van Veldhuisen DJ; Kema IP; de Vries EG; Schellens JH JAMA Oncol; 2016 Aug; 2(8):1030-7. PubMed ID: 27348762 [TBL] [Abstract][Full Text] [Related]
26. The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients. Sulaiman L; Hesham D; Abdel Hamid M; Youssef G Egypt Heart J; 2021 Mar; 73(1):20. PubMed ID: 33649999 [TBL] [Abstract][Full Text] [Related]
27. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series. Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708 [TBL] [Abstract][Full Text] [Related]
28. Assessing the cardiotoxicity of Epirubicin-based chemotherapy in patients with breast cancer using high-sensitivity cardiac troponin T, N-terminal pro b-type natriuretic peptide and soluble suppression of tumorigenicity-2. Isemede DA; Sharma A; Bailey J Ann Clin Biochem; 2022 Nov; 59(6):410-419. PubMed ID: 36154484 [TBL] [Abstract][Full Text] [Related]
29. Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial. Hao W; Liu S; Qin Y; Sun C; Chen L; Wu C; Bao Y Trials; 2017 Aug; 18(1):386. PubMed ID: 28830541 [TBL] [Abstract][Full Text] [Related]
30. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study. Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338 [TBL] [Abstract][Full Text] [Related]
31. Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors. Serrano JM; Mata R; González I; Del Castillo S; Muñiz J; Morales LJ; Espinosa MJ; Moreno F; Jiménez R; Cristobal C; Graupner C; Talavera P; Landaluce CG; Curcio A; Alonso J; Guerra JA; Alonso JJ Int J Cardiol; 2023 Jul; 382():52-59. PubMed ID: 37080467 [TBL] [Abstract][Full Text] [Related]
32. The Effect of Smartphone Apps Versus Supervised Exercise on Physical Activity, Cardiorespiratory Fitness, and Body Composition Among Individuals With Mild-to-Moderate Mobility Disability: Randomized Controlled Trial. Berglind D; Yacaman-Mendez D; Lavebratt C; Forsell Y JMIR Mhealth Uhealth; 2020 Feb; 8(2):e14615. PubMed ID: 32014846 [TBL] [Abstract][Full Text] [Related]
33. Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial. Scott JM; Thomas SM; Herndon JE; Douglas PS; Yu AF; Rusch V; Huang J; Capaci C; Harrison JN; Stoeckel KJ; Nilsen T; Edvardsen E; Michalski MG; Eves ND; Jones LW J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1456-1465. PubMed ID: 34658160 [TBL] [Abstract][Full Text] [Related]
34. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy. Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809 [TBL] [Abstract][Full Text] [Related]
35. Objectively-assessed physical activity and weight change in young adults: a randomized controlled trial. Unick JL; Lang W; Williams SE; Bond DS; Egan CM; Espeland MA; Wing RR; Tate DF; Int J Behav Nutr Phys Act; 2017 Dec; 14(1):165. PubMed ID: 29202850 [TBL] [Abstract][Full Text] [Related]
36. Short-Term Water- and Land-Based Exercise Training Comparably Improve Exercise Capacity and Vascular Function in Patients After a Recent Coronary Event: A Pilot Randomized Controlled Trial. Vasić D; Novaković M; Božič Mijovski M; Barbič Žagar B; Jug B Front Physiol; 2019; 10():903. PubMed ID: 31379605 [TBL] [Abstract][Full Text] [Related]
37. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Romano S; Fratini S; Ricevuto E; Procaccini V; Stifano G; Mancini M; Di Mauro M; Ficorella C; Penco M Br J Cancer; 2011 Nov; 105(11):1663-8. PubMed ID: 22068815 [TBL] [Abstract][Full Text] [Related]
38. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235 [TBL] [Abstract][Full Text] [Related]
39. Correlation of Speckle-Tracking Echocardiography with Traditional Biomarkers in Predicting Cardiotoxicity among Pediatric Hemato-Oncology Patients: A Comprehensive Evaluation of Anthracycline Dosages and Treatment Protocols. Ardelean AM; Olariu IC; Isac R; Jurac R; Stolojanu C; Murariu M; Toma AO; Braescu L; Mavrea A; Doros G Children (Basel); 2023 Aug; 10(9):. PubMed ID: 37761440 [TBL] [Abstract][Full Text] [Related]
40. Study protocol: the Fueling Learning through Exercise (FLEX) study - a randomized controlled trial of the impact of school-based physical activity programs on children's physical activity, cognitive function, and academic achievement. Wright CM; Duquesnay PJ; Anzman-Frasca S; Chomitz VR; Chui K; Economos CD; Langevin EG; Nelson ME; Sacheck JM BMC Public Health; 2016 Oct; 16(1):1078. PubMed ID: 27737676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]